Medpace President Sells $13.86M in MEDP Stock Post-Option Exercise
Medpace Holdings, Inc.
Subscribe to track MEDP
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Medpace President Sells $13.86M in MEDP Stock
Company: Medpace Holdings, Inc. (MEDP) Form: 4 | Filed: 2025-10-29 Significance: Medium
Insider: GEIGER JESSE J Title: President | Relationship: Officer
Transaction: • Type: Sell (following option exercise) • Shares: 23,028 • Avg. Price: $602.01 • Value: $13,863,219 • Owned After: 36,503 shares
Key Insight: The President exercised stock options and subsequently sold all acquired shares, realizing a significant gain. The sale represents nearly 39% of his prior holdings.
Market Context: This is a common executive compensation move. While the sale is large in dollar terms, it represents a very small fraction (<0.1%) of the company's total market cap and shares outstanding.
Comprehensive Analysis
SEC Filing Analysis: Medpace Holdings, Inc. (MEDP)
Executive Summary
- Trading Significance: Medium
- Key Takeaway: The President of Medpace Holdings, Inc. conducted a significant liquidity event, selling $13.86 million worth of stock immediately after exercising options. The sale disposed of nearly 39% of his direct holdings.
- Market Impact: The transaction is a common executive compensation strategy (cashless exercise and sell). While the dollar value is high, its impact on the market is likely neutral to low, as it represents a very small percentage of the company's total float and market cap.
Company Information
| Field | Value |
|---|---|
| Company | Medpace Holdings, Inc. |
| Ticker Symbol | MEDP |
| CIK | 0001668397 |
| Industry | SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH |
Insider Information
| Field | Value |
|---|---|
| Name | GEIGER JESSE J |
| CIK | 0001677399 |
| Title/Position | President |
| Relationship | Officer |
Transaction Details
This filing reports a series of transactions on two separate dates, constituting an option exercise and subsequent sale. The details below aggregate the total sale for clarity.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-27 & 2025-10-29 |
| Transaction Code | M (Exercise), S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 23,028 (Total Sold) |
| Price Per Share | $602.01 (Weighted Avg. Sale Price) |
| Total Value | $13,863,219.20 (Total Sale Value) |
| Shares Owned After | 36,503 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Total Transaction Value (Sale) | $13,863,219.20 |
| % of Market Cap ($16.80B) | 0.083% |
| Total Shares Transacted (Sale) | 23,028 |
| % of Shares Outstanding (28.09M) | 0.082% |
| Post-Transaction Ownership | 36,503 shares (0.13% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with a $16.80 billion market capitalization, a $13.86 million transaction is not material from a market perspective, representing less than 0.1% of the company's value.
- Ownership Concentration: The insider's post-transaction ownership of 36,503 shares constitutes a very small portion (0.13%) of the total shares outstanding, indicating low ownership concentration from this specific executive.
- Dilution Impact: The transaction involved exercising existing options, which were already accounted for in the company's diluted share count. The immediate sale of the acquired shares means there is no net increase in the insider's holdings from this event.
- Transaction Significance: While the transaction's size relative to the company is low, its significance is elevated to 'Medium' because the insider is the President and the sale represents a substantial portion (approx. 38.7%) of his personal holdings. This indicates a significant personal liquidity event.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transactions were coded 'M' (Exercise) followed by 'S' (Sale), a pattern typical of executives cashing in on vested stock options for compensation or tax purposes. The market generally views these pre-planned or compensation-related sales as less indicative of an insider's outlook on the company's future performance compared to open-market discretionary sales.
Volume & Sentiment
- Expected Volume Impact: Minimal. The number of shares sold is a tiny fraction of the company's float and likely to be absorbed by the market without significant price disruption.
- Sentiment Indicator: Neutral. The sale is substantial for the individual but not for the company. It is interpreted as a personal financial management decision rather than a bearish signal on the company's fundamentals.
Investment Insights
Positive Market Indicators
- The executive realized a substantial profit, with sale prices ($585.00 - $610.66) far exceeding the option exercise price ($166.73), reflecting strong stock performance.
Risk Factors
- A C-suite executive selling a large portion of their holdings, even if compensation-related, can sometimes be perceived negatively if it becomes a recurring pattern among top management.
Key Takeaways
- Compensation-Driven Sale: This is a classic example of an executive monetizing vested stock options, not a spontaneous open-market sale.
- Low Corporate Materiality: The sale's value and share count are immaterial relative to Medpace's large market capitalization and shares outstanding.
- Significant Personal Liquidity: For the insider, this was a major financial event, cashing out nearly 39% of his stock position.
Additional Context
Transaction Notes
- Footnotes: The filing notes the sales were made via a limit order placed during an open window. One of the sale prices is a weighted average, indicating multiple trades were executed to complete the order.
- Timing: The options were exercised on the same day they fully vested (October 27, 2025), and the shares were immediately sold, reinforcing the interpretation of a planned liquidity event.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
